Lista de obras -

A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive Phenotype.

artículo científico publicado en 2015

Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program

artículo científico publicado en 2009

Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience ⬇️

artículo científico publicado el 4 de abril de 2011

Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort

artículo científico publicado en 2020

Age-associated changes in blood pressure in a longitudinal study of healthy men and women

artículo científico publicado en 1997

Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer

artículo científico publicado en 2012

Association of energy intake with prostate cancer in a long-term aging study: Baltimore longitudinal study of aging (United States)

scientific article published on 01 February 2003

Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging

artículo científico publicado en 2004

Calcium intake and prostate cancer risk in a long-term aging study: the Baltimore Longitudinal Study of Aging

artículo científico publicado en 2002

Can a baseline prostate specific antigen level identify men who will have lower urinary tract symptoms later in life?

artículo científico publicado en 2005

Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?

artículo científico publicado en 2003

Comparison of Biochemical Recurrence-Free Survival after Radical Prostatectomy Triggered by Grade Reclassification during Active Surveillance and in Men Newly Diagnosed with Similar Grade Disease

artículo científico publicado en 2017

Conditional probability of reclassification in an active surveillance program for prostate cancer

artículo científico publicado en 2015

DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme

artículo científico publicado en 2009

Delayed versus immediate surgical intervention and prostate cancer outcome

artículo científico publicado en 2006

Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability

artículo científico publicado en 2006

Effect of intra-observer variation in prostate volume measurement on prostate-specific antigen density calculations among prostate cancer active surveillance participants

artículo científico publicado en 2011

Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer

scientific article published on 30 January 2012

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer

artículo científico publicado en 2016

Evaluation of Apparent Diffusion Coefficient as a Predictor of Grade Reclassification in Men on Active Surveillance for Prostate Cancer

scientific article published on 15 January 2020

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

artículo científico publicado en 1994

Expanded Criteria to Identify Men Eligible for Active Surveillance of Low Risk Prostate Cancer at Johns Hopkins: A Preliminary Analysis ⬇️

artículo científico publicado el 13 de mayo de 2013

Expectant management of nonpalpable prostate cancer with curative intent: preliminary results

artículo científico publicado en 2002

Expectant management of prostate cancer with curative intent

artículo científico publicado en 2001

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience

artículo científico publicado en 2007

Fluoroquinolone resistance in the rectal carriage of men in an active surveillance cohort: longitudinal analysis.

artículo científico publicado en 2014

Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer

scientific article published on 08 October 2018

Health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy in the phosphodiesterase type 5 ERA: impact of neurovascular bundle preservation

artículo científico publicado en 2005

Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer

artículo científico publicado en 2015

Low Prostate-specific Antigen and No Gleason Score Upgrade Despite More Extensive Cancer During Active Surveillance Predicts Insignificant Prostate Cancer at Radical Prostatectomy ⬇️

artículo científico publicado el 22 de agosto de 2012

Magnetic resonance-invisible versus magnetic resonance-visible prostate cancer in active surveillance: a preliminary report on disease outcomes

artículo científico publicado en 2014

Metabolic factors associated with benign prostatic hyperplasia

artículo científico publicado en 2006

Mixed-effects regression models for studying the natural history of prostate disease

artículo científico publicado en 1994

Multiparametric magnetic resonance imaging findings in men with low‐risk prostate cancer followed using active surveillance ⬇️

artículo científico publicado el 6 de marzo de 2013

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging

artículo científico publicado en 2005

Obesity does not adversely affect health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy

artículo científico publicado en 2005

PSA doubling time versus PSA velocity to predict high-risk prostate cancer: data from the Baltimore Longitudinal Study of Aging

artículo científico publicado en 2008

PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml

scientific article published on 01 June 2002

Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery

artículo científico publicado en 2015

Pathological Outcomes in Men with Low Risk and Very Low Risk Prostate Cancer: Implications on the Practice of Active Surveillance ⬇️

artículo científico publicado el 30 de abril de 2013

Prediagnostic plasma vitamin C levels and the subsequent risk of prostate cancer

artículo científico publicado en 2005

Predictors of Adverse Pathology in Men Undergoing Radical Prostatectomy Following Initial Active Surveillance

artículo científico publicado en 2015

Pro-prostate-specific antigen measurements in serum and tissue are associated with treatment necessity among men enrolled in expectant management for prostate cancer

artículo científico publicado en 2009

ProPSA and Diagnostic Biopsy Tissue DNA Content Combination Improves Accuracy to Predict Need for Prostate Cancer Treatment Among Men Enrolled in an Active Surveillance Program ⬇️

artículo científico publicado el 8 de enero de 2011

Prostate specific antigen predicts the long-term risk of prostate enlargement: results from the Baltimore Longitudinal Study of Aging

artículo científico publicado en 2002

Prostate specific antigen testing among the elderly--when to stop?

artículo científico publicado en 2009

Prostate specific antigen velocity risk count predicts biopsy reclassification for men with very low risk prostate cancer

artículo científico publicado en 2013

Prostate-specific antigen and all-cause mortality: results from the Baltimore Longitudinal Study On Aging

artículo científico publicado en 2004

Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program

artículo científico publicado en 2010

Prostate-specific antigen testing of older men.

artículo científico publicado en 1999

Prostate-specific antigen velocity risk count assessment: a new concept for detection of life-threatening prostate cancer during window of curability

artículo científico publicado en 2007

Reclassification rates are higher among African American men than Caucasians on active surveillance

artículo científico publicado en 2014

Repeat prostate biopsies predict location of index cancer in an active surveillance cohort ⬇️

artículo científico publicado el 28 de marzo de 2011

Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillance

artículo científico publicado en 2016

Risk stratification of men choosing surveillance for low risk prostate cancer

artículo científico publicado en 2010

Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer

scientific article published on 01 November 2000

Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density

artículo científico publicado en 2013

Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy

artículo científico publicado en 2005

Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization

artículo científico publicado en 2017

The Optimal Application of Prostate-Specific Antigen (PSA) Velocity to Predict High-Risk Disease.

artículo científico publicado en 2008

The Role of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Active Surveillance

artículo científico publicado en 2016

Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent

artículo científico publicado en 2008

Utility of multiparametric magnetic resonance imaging in the risk stratification of men with Grade Group 1 prostate cancer on active surveillance

scientific article published on 10 February 2020

Lista de obras de

A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive Phenotype.

Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program

Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience ⬇️

Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort

Age-associated changes in blood pressure in a longitudinal study of healthy men and women

Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer

Association of energy intake with prostate cancer in a long-term aging study: Baltimore longitudinal study of aging (United States)

Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging

Calcium intake and prostate cancer risk in a long-term aging study: the Baltimore Longitudinal Study of Aging

Can a baseline prostate specific antigen level identify men who will have lower urinary tract symptoms later in life?

Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?

Comparison of Biochemical Recurrence-Free Survival after Radical Prostatectomy Triggered by Grade Reclassification during Active Surveillance and in Men Newly Diagnosed with Similar Grade Disease

Conditional probability of reclassification in an active surveillance program for prostate cancer

DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme

Delayed versus immediate surgical intervention and prostate cancer outcome

Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability

Effect of intra-observer variation in prostate volume measurement on prostate-specific antigen density calculations among prostate cancer active surveillance participants

Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer

Evaluation of Apparent Diffusion Coefficient as a Predictor of Grade Reclassification in Men on Active Surveillance for Prostate Cancer

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

Expanded Criteria to Identify Men Eligible for Active Surveillance of Low Risk Prostate Cancer at Johns Hopkins: A Preliminary Analysis ⬇️

Expectant management of nonpalpable prostate cancer with curative intent: preliminary results

Expectant management of prostate cancer with curative intent

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience

Fluoroquinolone resistance in the rectal carriage of men in an active surveillance cohort: longitudinal analysis.

Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer

Health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy in the phosphodiesterase type 5 ERA: impact of neurovascular bundle preservation

Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer

Low Prostate-specific Antigen and No Gleason Score Upgrade Despite More Extensive Cancer During Active Surveillance Predicts Insignificant Prostate Cancer at Radical Prostatectomy ⬇️

Magnetic resonance-invisible versus magnetic resonance-visible prostate cancer in active surveillance: a preliminary report on disease outcomes

Metabolic factors associated with benign prostatic hyperplasia

Mixed-effects regression models for studying the natural history of prostate disease

Multiparametric magnetic resonance imaging findings in men with low‐risk prostate cancer followed using active surveillance ⬇️

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging

Obesity does not adversely affect health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy

PSA doubling time versus PSA velocity to predict high-risk prostate cancer: data from the Baltimore Longitudinal Study of Aging

PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml

Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery

Pathological Outcomes in Men with Low Risk and Very Low Risk Prostate Cancer: Implications on the Practice of Active Surveillance ⬇️

Prediagnostic plasma vitamin C levels and the subsequent risk of prostate cancer

Predictors of Adverse Pathology in Men Undergoing Radical Prostatectomy Following Initial Active Surveillance

Pro-prostate-specific antigen measurements in serum and tissue are associated with treatment necessity among men enrolled in expectant management for prostate cancer

ProPSA and Diagnostic Biopsy Tissue DNA Content Combination Improves Accuracy to Predict Need for Prostate Cancer Treatment Among Men Enrolled in an Active Surveillance Program ⬇️

Prostate specific antigen predicts the long-term risk of prostate enlargement: results from the Baltimore Longitudinal Study of Aging

Prostate specific antigen testing among the elderly--when to stop?

Prostate specific antigen velocity risk count predicts biopsy reclassification for men with very low risk prostate cancer

Prostate-specific antigen and all-cause mortality: results from the Baltimore Longitudinal Study On Aging

Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program

Prostate-specific antigen testing of older men.

Prostate-specific antigen velocity risk count assessment: a new concept for detection of life-threatening prostate cancer during window of curability

Reclassification rates are higher among African American men than Caucasians on active surveillance

Repeat prostate biopsies predict location of index cancer in an active surveillance cohort ⬇️

Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillance

Risk stratification of men choosing surveillance for low risk prostate cancer

Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer

Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density

Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy

Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization

The Optimal Application of Prostate-Specific Antigen (PSA) Velocity to Predict High-Risk Disease.

The Role of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Active Surveillance

Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent

Utility of multiparametric magnetic resonance imaging in the risk stratification of men with Grade Group 1 prostate cancer on active surveillance